Joan Finch
Audie L. Murphy Memorial VA Hospital · 7 works · 2,717 citations · h-index 5
Top works
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
- Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
- Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis
- 55 METABOLIC AND ANTI-INFLAMMATORY BENEFICIAL EFFECTS OF PIOGLITAZONE (PIO) TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND THEIR ASSOCIATIONS WITH HISTOLOGICAL IMPROVEMENT
- Hyperamylasemia and Acidemia: Is There an Association?